Matches in Wikidata for { <http://www.wikidata.org/entity/Q94403496> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q94403496 description "article scientifique publié en 2017" @default.
- Q94403496 description "wetenschappelijk artikel" @default.
- Q94403496 description "наукова стаття" @default.
- Q94403496 name "CSIG-20. INHIBITION OF AKT/SURVIVIN AND AKT/ID3 PATHWAYS BY CELECOXIB, A SELECTIVE COX-2 INHIBITOR, MAY HAVE PROMISING THERAPEUTIC POTENTIAL IN LOW-GRADE GLIOMA" @default.
- Q94403496 name "CSIG-20. INHIBITION OF AKT/SURVIVIN AND AKT/ID3 PATHWAYS BY CELECOXIB, A SELECTIVE COX-2 INHIBITOR, MAY HAVE PROMISING THERAPEUTIC POTENTIAL IN LOW-GRADE GLIOMA" @default.
- Q94403496 type Item @default.
- Q94403496 label "CSIG-20. INHIBITION OF AKT/SURVIVIN AND AKT/ID3 PATHWAYS BY CELECOXIB, A SELECTIVE COX-2 INHIBITOR, MAY HAVE PROMISING THERAPEUTIC POTENTIAL IN LOW-GRADE GLIOMA" @default.
- Q94403496 label "CSIG-20. INHIBITION OF AKT/SURVIVIN AND AKT/ID3 PATHWAYS BY CELECOXIB, A SELECTIVE COX-2 INHIBITOR, MAY HAVE PROMISING THERAPEUTIC POTENTIAL IN LOW-GRADE GLIOMA" @default.
- Q94403496 prefLabel "CSIG-20. INHIBITION OF AKT/SURVIVIN AND AKT/ID3 PATHWAYS BY CELECOXIB, A SELECTIVE COX-2 INHIBITOR, MAY HAVE PROMISING THERAPEUTIC POTENTIAL IN LOW-GRADE GLIOMA" @default.
- Q94403496 prefLabel "CSIG-20. INHIBITION OF AKT/SURVIVIN AND AKT/ID3 PATHWAYS BY CELECOXIB, A SELECTIVE COX-2 INHIBITOR, MAY HAVE PROMISING THERAPEUTIC POTENTIAL IN LOW-GRADE GLIOMA" @default.
- Q94403496 P1433 Q94403496-970B6799-84DD-4CB7-BAF7-704D9F19A570 @default.
- Q94403496 P1476 Q94403496-64E2E22C-2120-4BC8-AB21-DB6F082C377F @default.
- Q94403496 P2093 Q94403496-0EC79506-01DC-4343-9DDE-D6AFFC030C52 @default.
- Q94403496 P2093 Q94403496-1A58FC4C-EC24-4083-B7DC-A74B1972A3E6 @default.
- Q94403496 P2093 Q94403496-1EFC3A46-525A-40DE-8459-FEDEFEEFC896 @default.
- Q94403496 P2093 Q94403496-20AF735F-BB0B-4076-990A-A6E222A4238D @default.
- Q94403496 P2093 Q94403496-31CF8229-93AC-4949-960B-DA70A3C891E3 @default.
- Q94403496 P2093 Q94403496-6278C719-689C-4BF3-8E60-207AB093753B @default.
- Q94403496 P2093 Q94403496-72819B4F-3C5F-46D8-93BA-D37C4E6F3ABD @default.
- Q94403496 P2093 Q94403496-F5860CE9-D930-4CA7-9E8A-1A1EE8841D3A @default.
- Q94403496 P2093 Q94403496-F9477D3D-638F-489C-AF5C-81195109B59A @default.
- Q94403496 P304 Q94403496-E7817F44-95D5-45F9-BF04-6271492C4D64 @default.
- Q94403496 P31 Q94403496-4EAB61FE-0CDD-4200-9BC6-98822224183C @default.
- Q94403496 P356 Q94403496-9B77AD1D-77C6-4A78-8E33-9F6B3295BC76 @default.
- Q94403496 P433 Q94403496-FFAE6BB6-AC33-4E95-8855-5B3F8D9C5E5A @default.
- Q94403496 P478 Q94403496-91D83277-3D24-45CF-A2E1-DEC39476E807 @default.
- Q94403496 P577 Q94403496-2D965B04-D037-4065-92F9-DE575D029EE5 @default.
- Q94403496 P932 Q94403496-5B35397F-FFA9-4B83-BE8D-9177562AF186 @default.
- Q94403496 P356 NOX168.214 @default.
- Q94403496 P1433 Q15724471 @default.
- Q94403496 P1476 "CSIG-20. INHIBITION OF AKT/SURVIVIN AND AKT/ID3 PATHWAYS BY CELECOXIB, A SELECTIVE COX-2 INHIBITOR, MAY HAVE PROMISING THERAPEUTIC POTENTIAL IN LOW-GRADE GLIOMA" @default.
- Q94403496 P2093 "Akiko Sumi" @default.
- Q94403496 P2093 "Aya Sato" @default.
- Q94403496 P2093 "Izumi Yamaguchi" @default.
- Q94403496 P2093 "Keiko Kitazato" @default.
- Q94403496 P2093 "Kenji Shono" @default.
- Q94403496 P2093 "Kohei Nakajima" @default.
- Q94403496 P2093 "Shinji Nagahiro" @default.
- Q94403496 P2093 "Toshitaka Fujihara" @default.
- Q94403496 P2093 "Yoshifumi Mizobuchi" @default.
- Q94403496 P304 "vi54-vi54" @default.
- Q94403496 P31 Q13442814 @default.
- Q94403496 P356 "10.1093/NEUONC/NOX168.214" @default.
- Q94403496 P433 "Suppl 6" @default.
- Q94403496 P478 "19" @default.
- Q94403496 P577 "2017-11-06T00:00:00Z" @default.
- Q94403496 P932 "5691934" @default.